Inao, Touko <br/><br/>
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Jul 2012 
 - 89-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-011-1930-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Autophagy<br/>Breast Neoplasms--drug therapy<br/>Caspases--metabolism<br/>Cell Cycle Checkpoints<br/>Cell Cycle Proteins--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Shape--drug effects<br/>Cell Survival--drug effects<br/>DEAD Box Protein 58<br/>DEAD-box RNA Helicases--metabolism<br/>Drug Carriers<br/>Female<br/>Humans<br/>Interferon-Induced Helicase, IFIH1<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Poly I-C--pharmacology<br/>Receptors, Immunologic<br/>Toll-Like Receptor 3--metabolism<br/>Transfection<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays